CEACAM5 and breast carcinoma: Moreover, quantitative molecular diagnosis including carcinoembryonic antigen (CEA) and cytokeratin-19 (CK-19) assays targeting cancer cells in axillary WF revealed that CEA and CK-19 were predictor for locoregional recurrence in breast cancer patients with mastectomy [12].